Medline Inc.
MDLNNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 26, 2026Last filing: 10-Q on Nov 4, 2026Score 2/3060% above fair value
$37.04−0.80 (-2.11%)
Close on Nov 20, 2026Market cap $48.70BP/E –Yield –
Medline Consolidated Adjusted EBITDA: $960M in Q3 2026, up 11.8% from a year earlier.
Latest, Q3 2026
960
Period ended Sep 30, 2026
Change on a year earlier
+11.8%
859 in Q3 2025
History
8 quarters
Since Q4 2024
Sources
4
Documents cited below
Where the Q3 2026 figure comes from
Source: SEC Form 8-K Ex. 99.1 Q3 2026 Earnings Release (2026-11-04) ↗
Reported in SEC Form 8-K Earnings Releases, Form 10-K, Form 10-Q & Form 424B4.
quarterly history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Consolidated Adjusted EBITDA ($M) | Year on year | Source |
|---|---|---|---|---|
| Q3 2026 | Sep 30, 2026 | 960 | +11.8% | SEC Form 8-K Ex. 99.1 Q3 2026 Earnings Release (2026-11-04) ↗ |
| Q2 2026 | Jun 30, 2026 | 1,060 | +13.4% | SEC Form 8-K Ex. 99.1 Q2 2026 Earnings Release (2026-08-05) ↗ |
| Q1 2026 | Mar 31, 2026 | 776 | -10.6% | SEC Form 8-K Ex. 99.1 Q1 2026 Earnings Release (2026-05-06) ↗ |
| Q4 2025 | Dec 31, 2025 | 805 | -0.6% | SEC Form 8-K Ex. 99.1 Q4 & FY2025 Earnings Release (2026-02-25) ↗ |
| Q3 2025 | Sep 30, 2025 | 859 | – | SEC Form 8-K Ex. 99.1 Q3 2026 Earnings Release (2026-11-04) ↗ |
| Q2 2025 | Jun 30, 2025 | 935 | – | SEC Form 8-K Ex. 99.1 Q2 2026 Earnings Release (2026-08-05) ↗ |
| Q1 2025 | Mar 31, 2025 | 868 | – | SEC Form 8-K Ex. 99.1 Q1 2026 Earnings Release (2026-05-06) ↗ |
| Q4 2024 | Dec 31, 2024 | 810 | – | SEC Form 8-K Ex. 99.1 Q4 & FY2025 Earnings Release (2026-02-25) ↗ |
Breakdown
What makes up consolidated Adjusted EBITDA
- Consolidated Adjusted EBITDA Margin12.2% · Q3 2026
- Consolidated Gross Profit Margin24.5% · Q3 2026
- EBITDA Adjustment — Non-Cash LIFO & Inventory Step-Up122 · Q3 2026
- EBITDA Adjustment — Stock-Based Compensation29 · Q3 2026
- EBITDA Adjustment — Transaction, Integration & IPO Costs30 · Q3 2026
- EBITDA Adjustment — Other Non-Core Charges16 · Q3 2026
Cite this data
StockData. (2026). Medline Consolidated Adjusted EBITDA ($M), quarterly Q4 2024–Q3 2026 [Data set]. Compiled from Medline SEC filings and investor materials. https://stockdatahq.com/stocks/mdln/kpis/ng-adj-ebitda
See every metric in the Medline KPI table. Data updated Nov 7, 2026.
See a number that looks wrong?